Patrick Moriarty
Professor, Clinical Pharmacology · University of Kansas School of Medicine
Credentials: · · ·
History
- 1984–1987
Internal Medicine
- 1980–1984
Doctor of Medicine
Research
European Heart Journal · 2022 · 1,074 citations
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
New England Journal of Medicine · 2020 · 828 citations
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
New England Journal of Medicine · 2023 · 716 citations
23 papers
15 papers
13 papers
13 papers
13 papers
- SB
12 papers
- BD
11 papers
11 papers
Clinical trials
- 2012–2014
Principal investigator · Completed · Early phase 1
Patrick Moriarty, MD, FACP, FACC
- 2011–2013
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
Principal investigator · Completed · Phase 4
University of Kansas Medical Center
- 2009–2010
Alternative Options to Minimize Niacin-Induced Flushing
Principal investigator · Completed
Patrick Moriarty, MD, FACP, FACC
- 2007–2008
(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol
Principal investigator · Completed
B. Braun Medical Inc.